Efficacy and Safety of Sesame Oil Cake Extract on Improvement of Cognitive Function

July 24, 2019 updated by: Young Chul Chung, Chonbuk National University Hospital

A 12 Weeks, Randomized, Double-blind, Placebo-controlled Human Trial to Evaluate the Efficacy and Safety of Sesame Oil Cake Extract on Improvement of Cognitive Function

This study was the efficacy and safety of Sesame oil cake extract on improvement of Cognitive Function

Study Overview

Detailed Description

This study was a 12 weeks, randomized, double-blind, placebo-controlled human trial to evaluate. 70 subjects were participated in Sesame Oil Cake Extract or placebo group. To evaluate the changes of the evaluation items when Sesame Oil Cake Extract was taken three times a day compared with placebo.

Study Type

Interventional

Enrollment (Actual)

70

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Jeonju, Korea, Republic of
        • Department of Psychiatry, Chonbuk National University Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

60 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Those who are at least 60 years of age at screening
  • Those who word list memory / recollection/ recognition test scores of CERAD -K decrease 1-2 SD number of normal value
  • Those who agree to voluntary participation and to comply with the Notice after fully hearing and understanding the details of this human trial

Exclusion Criteria:

  • Those with a past history of treatment with Axis I disorder in SCID(Structured Clinical Interview for DSM-IV) which is a structured clinical interview in the Diagnostic and Statistical Manual of Mental Disorders at Screening or who have been treated within the last 3 years
  • Those with alcohol abuse or dependence within the last 3 months
  • Those who have clinically significant following severe illness (Epilepsy, mental retardation, brain nervous system diseases, endocrine diseases, blood / malignant tumors, cardiovascular diseases, Crohn's disease, etc.)
  • Those who shows the following results in the Laboratory test

    • AST, ALT > 3 times upper limit of normal range
    • Other significant laboratory test opinion
  • Those who take any prescription medicines or herbal medicines within 2 weeks before the first ingestion date or take any OTC or vitamin preparations within 1 week
  • Those who participate in other human trial within 2 months before the first ingestion
  • Those who whole blood donation within 1 months before the first ingestion or Component blood donation within 2 weeks
  • Those who is deemed unsuitable for participating in the human trial due to other reasons

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: PREVENTION
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: DOUBLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Sesame Oil Cake Extract
Sesame Oil Cake Extract 1.5 g/day for 12 weeks
Sesame Oil Cake Extract 1.5 g/day for 12 weeks.
PLACEBO_COMPARATOR: Placebo
placebo for 12 weeks
placebo for 12 weeks.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes of Visual learning test
Time Frame: 12 weeks
Visual learning test was measured in baseline and 12 weeks.
12 weeks
Changes of Visual working memory test
Time Frame: 12 weeks
Visual working memory test was measured in baseline and 12 weeks.
12 weeks
Changes of Verbal learning test
Time Frame: 12 weeks
Verbal learning test was measured in baseline and 12 weeks.
12 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes of the Montreal Cognitive Assessment(MoCA-K)
Time Frame: 12 weeks

The cognitive function evaluation using the Montreal Cognitive Assessment(MoCA-K) is a total of 8 items, and evaluates cognitive functions such as time / execution power, vocabulary, memory, attention, sentence, abstraction, delayed recall, and orientation.

Time / execution power's total score is 5 points, vocabulary's total score is 3 points, attention's total score is 3 points, sentence's total score is 3 points, abstraction's total score is 2 points, delayed recall's total score is 5 points, orientation's total score is 6 points. It takes about 10 minutes to complete, and the total score is 30 points and total score make sum score. A score of 23 points or more is regarded as normal. If you have less than 6 years of education, add 1 point.

It takes about 10 minutes to complete, and the score is 30 points. A score of 23 points or more is regarded as normal. If you have less than 6 years of education, add 1 point.

12 weeks
Changes of beta-amyloid
Time Frame: 12 weeks
Beta-amyloid(pg/mL) was measured in baseline and 12 weeks.
12 weeks
Changes of Oxidation index(8-OHdG)
Time Frame: 12 weeks
Oxidation index(8-OHdG)(ng/mL) was measured in baseline and 12 weeks.
12 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

September 15, 2017

Primary Completion (ACTUAL)

August 10, 2018

Study Completion (ACTUAL)

August 10, 2018

Study Registration Dates

First Submitted

January 30, 2019

First Submitted That Met QC Criteria

January 30, 2019

First Posted (ACTUAL)

February 1, 2019

Study Record Updates

Last Update Posted (ACTUAL)

July 25, 2019

Last Update Submitted That Met QC Criteria

July 24, 2019

Last Verified

July 1, 2019

More Information

Terms related to this study

Other Study ID Numbers

  • KH_CF_SE

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cognitive Function

Clinical Trials on Sesame Oil Cake Extract

Subscribe